Skin Cancer

Relation Between Skin Cancer Medication and Dermatologic Adverse Events
May 07, 2021

A study at AAD VMX 2021 presented data on possible association between sex, skin cancer medication, and dermatologic adverse events.

FDA Grants Orphan Drug Status to ITIL-168 for Melanoma
May 05, 2021

The FDA has granted an Orphan Drug designation to the investigational tumor-infiltrating lymphocyte therapy ITIL-168 for the treatment of patients with stage IIB to IV melanoma.

Preventing Skin Cancer Through Sun Protection
April 30, 2021

In this video interview, Melissa Stenstrom, MD, discusses how physicians can promote the use of sun protection and regular skin cancer screenings to help prevent skin cancer among their patients.